Cargando…

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis

INTRODUCTION: Although the efficacy of 5-aminosalicylic acid (ASA) suppositories for ulcerative colitis (UC) has been reported in many studies, many studies have also described poor adherence to 5-ASA suppository regimens. We aimed to identify the clinical background factors that influence adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Kazuhiko, Takagi, Tomohisa, Mizushima, Katsura, Asaeda, Kohei, Kubota-Kajiwara, Mariko, Sugaya, Takeshi, Kashiwagi, Saori, Minagawa, Yuki, Hotta, Yuma, Tanaka, Makoto, Inoue, Ken, Katada, Kazuhiro, Kamada, Kazuhiro, Ishikawa, Takeshi, Yasuda, Hiroaki, Konishi, Hideyuki, Kishimoto, Mitsuo, Naito, Yuji, Itoh, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601951/
https://www.ncbi.nlm.nih.gov/pubmed/37901338
http://dx.doi.org/10.1159/000533543
_version_ 1785126296877006848
author Uchiyama, Kazuhiko
Takagi, Tomohisa
Mizushima, Katsura
Asaeda, Kohei
Kubota-Kajiwara, Mariko
Sugaya, Takeshi
Kashiwagi, Saori
Minagawa, Yuki
Hotta, Yuma
Tanaka, Makoto
Inoue, Ken
Katada, Kazuhiro
Kamada, Kazuhiro
Ishikawa, Takeshi
Yasuda, Hiroaki
Konishi, Hideyuki
Kishimoto, Mitsuo
Naito, Yuji
Itoh, Yoshito
author_facet Uchiyama, Kazuhiko
Takagi, Tomohisa
Mizushima, Katsura
Asaeda, Kohei
Kubota-Kajiwara, Mariko
Sugaya, Takeshi
Kashiwagi, Saori
Minagawa, Yuki
Hotta, Yuma
Tanaka, Makoto
Inoue, Ken
Katada, Kazuhiro
Kamada, Kazuhiro
Ishikawa, Takeshi
Yasuda, Hiroaki
Konishi, Hideyuki
Kishimoto, Mitsuo
Naito, Yuji
Itoh, Yoshito
author_sort Uchiyama, Kazuhiko
collection PubMed
description INTRODUCTION: Although the efficacy of 5-aminosalicylic acid (ASA) suppositories for ulcerative colitis (UC) has been reported in many studies, many studies have also described poor adherence to 5-ASA suppository regimens. We aimed to identify the clinical background factors that influence adherence to 5-ASA suppositories to improve adherence and efficacy of the treatment. METHODS: We conducted a retrospective cohort study of 61 patients with active UC who were using 5-ASA suppositories. All patients underwent endoscopy and rectal biopsy for histological diagnosis prior to 5-ASA suppository treatment. The efficacy of 5-ASA suppository treatment was compared in relation to clinical background factors (sex, age, disease duration, disease type, clinical activity, Ulcerative Colitis Endoscopic Index of Severity, histological activity, serum C-reactive protein level, concomitant use of immunomodulators, history of steroid use, and dose of oral 5-ASA). RESULTS: The efficacy of 5-ASA suppositories was significantly related to low Lichtiger Colitis Activity Index (LCAI) scores and proctitis type prior to its use. In terms of sex, females tended to show higher efficacy. Multivariate logistic regression analysis using these three factors showed high predictive value for the efficacy of 5-ASA suppositories (AUC, 0.788; sensitivity, 87.2%; and specificity, 63.7%). CONCLUSION: This study is the first to extract clinical background factors for predicting the efficacy of 5-ASA suppositories. The use of 5-ASA suppositories in patients who are expected to show efficacy will be effective in improving patient co-operation.
format Online
Article
Text
id pubmed-10601951
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-106019512023-10-27 Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis Uchiyama, Kazuhiko Takagi, Tomohisa Mizushima, Katsura Asaeda, Kohei Kubota-Kajiwara, Mariko Sugaya, Takeshi Kashiwagi, Saori Minagawa, Yuki Hotta, Yuma Tanaka, Makoto Inoue, Ken Katada, Kazuhiro Kamada, Kazuhiro Ishikawa, Takeshi Yasuda, Hiroaki Konishi, Hideyuki Kishimoto, Mitsuo Naito, Yuji Itoh, Yoshito Inflamm Intest Dis Research Article INTRODUCTION: Although the efficacy of 5-aminosalicylic acid (ASA) suppositories for ulcerative colitis (UC) has been reported in many studies, many studies have also described poor adherence to 5-ASA suppository regimens. We aimed to identify the clinical background factors that influence adherence to 5-ASA suppositories to improve adherence and efficacy of the treatment. METHODS: We conducted a retrospective cohort study of 61 patients with active UC who were using 5-ASA suppositories. All patients underwent endoscopy and rectal biopsy for histological diagnosis prior to 5-ASA suppository treatment. The efficacy of 5-ASA suppository treatment was compared in relation to clinical background factors (sex, age, disease duration, disease type, clinical activity, Ulcerative Colitis Endoscopic Index of Severity, histological activity, serum C-reactive protein level, concomitant use of immunomodulators, history of steroid use, and dose of oral 5-ASA). RESULTS: The efficacy of 5-ASA suppositories was significantly related to low Lichtiger Colitis Activity Index (LCAI) scores and proctitis type prior to its use. In terms of sex, females tended to show higher efficacy. Multivariate logistic regression analysis using these three factors showed high predictive value for the efficacy of 5-ASA suppositories (AUC, 0.788; sensitivity, 87.2%; and specificity, 63.7%). CONCLUSION: This study is the first to extract clinical background factors for predicting the efficacy of 5-ASA suppositories. The use of 5-ASA suppositories in patients who are expected to show efficacy will be effective in improving patient co-operation. S. Karger AG 2023-08-10 /pmc/articles/PMC10601951/ /pubmed/37901338 http://dx.doi.org/10.1159/000533543 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Research Article
Uchiyama, Kazuhiko
Takagi, Tomohisa
Mizushima, Katsura
Asaeda, Kohei
Kubota-Kajiwara, Mariko
Sugaya, Takeshi
Kashiwagi, Saori
Minagawa, Yuki
Hotta, Yuma
Tanaka, Makoto
Inoue, Ken
Katada, Kazuhiro
Kamada, Kazuhiro
Ishikawa, Takeshi
Yasuda, Hiroaki
Konishi, Hideyuki
Kishimoto, Mitsuo
Naito, Yuji
Itoh, Yoshito
Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title_full Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title_fullStr Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title_full_unstemmed Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title_short Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
title_sort clinical background factors as predictors of the efficacy of 5-aminosalicylic acid suppositories in patients with ulcerative colitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601951/
https://www.ncbi.nlm.nih.gov/pubmed/37901338
http://dx.doi.org/10.1159/000533543
work_keys_str_mv AT uchiyamakazuhiko clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT takagitomohisa clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT mizushimakatsura clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT asaedakohei clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT kubotakajiwaramariko clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT sugayatakeshi clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT kashiwagisaori clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT minagawayuki clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT hottayuma clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT tanakamakoto clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT inoueken clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT katadakazuhiro clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT kamadakazuhiro clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT ishikawatakeshi clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT yasudahiroaki clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT konishihideyuki clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT kishimotomitsuo clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT naitoyuji clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis
AT itohyoshito clinicalbackgroundfactorsaspredictorsoftheefficacyof5aminosalicylicacidsuppositoriesinpatientswithulcerativecolitis